Latest News

Read the latest updates from Quotient Sciences.
Quotient Sciences Wins 2025 CDMO Leadership Awards
Awards & Recognition

Quotient Sciences Recognized as a Winner of 2025 CDMO Leadership Awards

Read More

136 - 140 of 153 results

An accomplished leader in the pharmaceutical industry with over 35 years’ experience, Claes Glassell has been appointed as non‐executive chairman of the Quotient Sciences board of directors. Glassell has held numerous leadership positions, ...

Learn more

Quotient Sciences and global investment firm Permira announced that a company backed by the Permira Funds has signed a definitive agreement to acquire a majority stake in Quotient Sciences.

Learn more
Dr. Andrew Lewis
News & Announcements, Dr. Andrew LewisAndy Lewis appointed as Secretary of Controlled Release SocietyBy: Dr. Andy Lewis
News & Announcements, Dr. Andrew LewisAndy Lewis appointed as Secretary of Controlled Release SocietyBy: Dr. Andy Lewis

Quotient Sciences (“Quotient”), a leading drug development services and manufacturing organization, is pleased to announce that its Vice President of Pharmaceutical Sciences, Andy Lewis, has been appointed as Secretary of the Controlled Rel...

Learn more

Quotient Sciences announced that it has received a Transatlantic Growth Award at a ceremony hosted by BritishAmerican Business in London.

Learn more

Paul Quigley shared his thoughts on the importance of flexibility, collaboration and innovation for the modern CDMO in Contract Pharma.

Learn more
Upcoming Events
Schedule a meeting with us at an upcoming industry event.